Hirakata, Japan

Teruaki Imada


Average Co-Inventor Count = 8.4

ph-index = 3

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1997-2000

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Teruaki Imada: Innovator in Heterocyclic Compounds

Introduction

Teruaki Imada, an accomplished inventor based in Hirakata, Japan, has made significant contributions to the field of medicinal chemistry. With a total of five patents to his name, his work predominantly focuses on heterocyclic amide compounds, which have promising applications in pharmaceuticals.

Latest Patents

Among his latest patents, Teruaki Imada has developed innovative compounds that include the following:

1. Heterocyclic amide compounds and medicinal uses thereof

2. Heterocyclic amide compounds and pharmaceutical use of the same

These advancements reflect his commitment to enhancing therapeutic options through innovative chemical solutions.

Career Highlights

Throughout his career, Teruaki Imada has been associated with prominent companies in the pharmaceutical industry, including The Green Cross Corporation and Yoshitomi Pharmaceutical Industries, Ltd. His work in these organizations has enabled him to develop and refine his innovative ideas, pushing the boundaries of medicinal research.

Collaborations

Collaboration plays a vital role in innovation, and Teruaki Imada has had the privilege of working alongside esteemed colleagues, such as Atsuyuki Ashimori and Masahiro Eda. These partnerships have likely fostered a creative environment conducive to breakthrough discoveries in pharmaceutical development.

Conclusion

Teruaki Imada stands out as a noteworthy inventor whose contributions to the field of heterocyclic compounds are paving the way for new medicinal applications. His patents not only showcase his expertise but also highlight the importance of collaboration in the pursuit of innovation within the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…